Arama Sonuçları - Nathan Robison

  • Gösterilen 1 - 13 sonuçlar arası kayıtlar. 13
Sonuçları Daraltın
  1. 1
    Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells

    Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells Yazar: Daofeng Liu, Liping Song, Vita S. Brawley, Nathan Robison, Jie Wei, Xiuhua Gao, Gengwen Tian, Ashley Margol, Nabil Ahmed, Shahab Asgharzadeh, Leonid S. Metelitsa

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy

    Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy Yazar: Stephanie Toll, Tran N. Hung, Jennifer Cotter, Alexander R. Judkins, Benita Tamrazi, Jaclyn A. Biegel, Girish Dhall, Nathan Robison, Kaaren Waters, Palak Patel, Robert Cooper, Ashley Margol

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Long‐term outcome of 4,040 children diagnosed with pediatric low‐grade gliomas: An analysis of the Surveillance Epidemiology and End Results (SEER) database

    Long‐term outcome of 4,040 children diagnosed with pediatric low‐grade gliomas: An analysis of the Surveillance Epidemiology and End Results (SEER) database Yazar: Pratiti Bandopadhayay, Guillaume Bergthold, Wendy B. London, Liliana Goumnerova, Andrés Morales La Madrid, Karen J. Marcus, Dongjing Guo, Nicole J. Ullrich, Nathan Robison, Susan Chi, Rameen Beroukhim, Mark W. Kieran, Peter Manley

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Tumor-Associated Macrophages in SHH Subgroup of Medulloblastomas

    Tumor-Associated Macrophages in SHH Subgroup of Medulloblastomas Yazar: Ashley Margol, Nathan Robison, Janahan Gnanachandran, Long Hung, Rebekah Kennedy, Marzieh Vali, Girish Dhall, Jonathan L. Finlay, Anat Erdreich‐Epstein, Mark D. Krieger, Rachid Drissi, Maryam Fouladi, Floyd H. Gilles, Alexander R. Judkins, Richard Sposto, Shahab Asgharzadeh

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy

    Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy Yazar: Stefan Blüml, Ashley Margol, Richard Sposto, Rebekah Kennedy, Nathan Robison, Marzieh Vali, Long Hung, Sakunthala Muthugounder, Jonathan L. Finlay, Anat Erdreich‐Epstein, Floyd H. Gilles, Alexander R. Judkins, Mark D. Krieger, Girish Dhall, Marvin D. Nelson, Shahab Asgharzadeh

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)

    Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047) Yazar: Michelle Monje, Tabitha Cooney, John Glod, Jie Huang, Cody J. Peer, Damien Faury, Patricia Baxter, Kim Kramer, Alicia Lenzen, Nathan Robison, Lindsay Kilburn, Anna Vinitsky, William D. Figg, Nada Jabado, Maryam Fouladi, Jason Fangusaro, Arzu Onar‐Thomas, Ira J. Dunkel, Katherine E Warren

    Baskı/Yayın Bilgisi 2023
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    A phase II trial of a multi‐agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer

    A phase II trial of a multi‐agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer Yazar: Nathan Robison, Federico Campigotto, Susan Chi, Peter Manley, Christopher D. Turner, Mary Ann Zimmerman, Christine Chordas, Annette M. Werger, Jeffrey C. Allen, Stewart Goldman, Joshua B. Rubin, Michael S. Isakoff, Wilbur J. Pan, Ziad Khatib, Melanie Comito, Anne Bendel, Jay B. Pietrantonio, Laura Kondrat, Shannon Hubbs, Donna Neuberg, Mark W. Kieran

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study

    A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibroma... Yazar: Nicole J. Ullrich, Sanjay P. Prabhu, Alyssa Reddy, Michael J. Fisher, Roger J. Packer, Stewart Goldman, Nathan Robison, David H. Gutmann, David Viskochil, Jeffrey C. Allen, Bruce R. Korf, Alan Cantor, Gary Cutter, Coretta Thomas, John P. Perentesis, Tomoyuki Mizuno, Alexander A. Vinks, Peter Manley, Susan Chi, Mark W. Kieran

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas

    NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibrom... Yazar: Brian Weiss, Pamela L. Wolters, Scott R. Plotkin, Brigitte C. Widemann, James H. Tonsgard, Jaishri O. Blakeley, Jeffrey C. Allen, Elizabeth K. Schorry, Bruce R. Korf, Nathan Robison, Stewart Goldman, Alexander A. Vinks, Chie Emoto, Tsuyoshi Fukuda, Coretta Thomas Robinson, Gary Cutter, Lloyd J. Edwards, Eva Dombi, Nancy Ratner, Roger J. Packer, Michael J. Fisher

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus

    MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus Yazar: Peter de Blank, Andrea M. Gross, Srivandana Akshintala, Jaishri O. Blakeley, Gideon Bollag, Ashley Cannon, Eva Dombi, Jason Fangusaro, Bruce D. Gelb, Darren Hargrave, AeRang Kim, Laura J. Klesse, Mignon L. Loh, Staci Martin, Christopher L. Moertel, Roger J. Packer, Jonathan M. Payne, Katherine A. Rauen, Jonathan J. Rios, Nathan Robison, Elizabeth K. Schorry, Kevin Shannon, David A. Stevenson, Elliot Stieglitz, Nicole J. Ullrich, Karin S. Walsh, Brian Weiss, Pamela L. Wolters, Kaleb Yohay, Marielle E. Yohe, Brigitte C. Widemann, Michael J. Fisher

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma

    Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma Yazar: Nalin Gupta, Liliana Goumnerova, Peter Manley, Susan Chi, Donna Neuberg, Mäneka Puligandla, Jason Fangusaro, Stewart Goldman, Tadanori Tomita, Tord D. Alden, Arthur J. DiPatri, Joshua B. Rubin, Karen Gauvain, David D. Limbrick, Jeffrey R. Leonard, J. Geyer, Sarah Leary, Samuel R. Browd, Zhihong Wang, Sandeep Sood, Anne Bendel, Mahmoud G. Nagib, Sharon L. Gardner, Matthias A. Karajannis, David H. Harter, Kanyalakshmi Ayyanar, William Gump, Daniel C. Bowers, Bradley E. Weprin, Tobey J. MacDonald, Dolly Aguilera, Barunashish Brahma, Nathan Robison, Erin N. Kiehna, Mark D. Krieger, Eric Sandler, Philipp R. Aldana, Ziad Khatib, John Ragheb, Sanjiv Bhatia, Sabine Mueller, Anu Banerjee, Amy-Lee Bredlau, S. Gururangan, Herbert E. Fuchs, Kenneth J. Cohen, George I. Jallo, Kathleen Dorris, Michael Handler, Melanie Comito, Mark S. Dias, Kellie J. Nazemi, Lissa Baird, Jeff Murray, Neal I. Lindeman, Jason L. Hornick, Hayley Malkin, Claire Sinai, Lianne Greenspan, Karen Wright, Michael D. Prados, Pratiti Bandopadhayay, Keith L. Ligon, Mark W. Kieran

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    HGG-11. Clinical characteristics and clinical evolution of a large cohort of pediatric patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion.

    HGG-11. Clinical characteristics and clinical evolution of a large cohort of pediatric patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TR... Yazar: Audrey‐Anne Lamoureux, Michael Fisher, Lauriane Lemelle, Elke Pfaff, Christof M. Kramm, Bram De Wilde, Bernarda Kazanowska, Caroline Hutter, Stefan M. Pfister, Dominik Sturm, David Jones, Daniel Orbach, Gaëlle Pierron, Scott Raskin, Alexander Drilon, Eli L. Diamond, Guilherme Harada, Michal Zápotocký, Benjamin Ellezam, Alexander G. Weil, Dominic Venne, Marc Barritault, Pierre Leblond, Hallie Coltin, Rawan Hammad, Uri Tabori, Cynthia Hawkins, Jordan R. Hansford, Déborah Meyran, Craig Erker, Kathryn McFadden, Mariko Sato, Nicholas G. Gottardo, Hetal Dholaria, Dorte Schou Nørøxe, Hiroaki Goto, David S. Ziegler, Frank Y. Lin, D. Williams Parsons, Holly Lindsay, Tai‐Tong Wong, Yen‐Lin Liu, Kuo-Sheng Wu, Andrea Flynn Franson, Eugene I. Hwang, Ana Aguilar-Bonilla, Sylvia Cheng, Chantel Cacciotti, Maura Massimino, Elisabetta Schiavello, Paul Wood, Lindsey M. Hoffman, Andréa Maria Cappellano, Álvaro Lassaletta, An Van Damme, Anna Llort, Nicolas U. Gerber, Mariella Spalato Ceruso, Anne Bendel, Maggie Skrypek, Dima Hamideh, Naureen Mushtaq, Andrew W. Walter, Nada Jabado, Aysha Alsahlawi, Jean‐Pierre Farmer, Christina Coleman Abadi, Sabine Mueller, Claire Mazewski, Dolly Aguilera, Nathan Robison, Katrina O’Halloran, Samuel Abbou, Pablo Berlanga, Birgit Geoerger, Ingrid Øra, Christopher L. Moertel, Evangelia Razis, Anastasia Vernadou, François Doz, Theodore W. Laetsch, Sébastien Perreault

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Clinical characteristics and outcome of central nervous system tumors harboring NTRK gene fusions

    Clinical characteristics and outcome of central nervous system tumors harboring NTRK gene fusions Yazar: Audrey‐Anne Lamoureux, Michael J. Fisher, Lauriane Lemelle, Elke Pfaff, Pouneh Amir-Yazdani, Christof M. Kramm, Bram De Wilde, Bernarda Kazanowska, Caroline Hutter, Stefan M. Pfister, Dominik Sturm, David Jones, Daniel Orbach, Gaëlle Pierron, Scott Raskin, Alexander Drilon, Eli L. Diamond, Guilherme Harada, Michal Zápotocký, Josef Zámečnı́k, Lenka Krsková, Benjamin Ellezam, Alexander G. Weil, Dominic Venne, Marc Barritault, Pierre Leblond, Hallie Coltin, Rawan Hammad, Uri Tabori, Cynthia Hawkins, Jordan R. Hansford, Déborah Meyran, Craig Erker, Kathryn McFadden, Mariko Sato, Nicholas G. Gottardo, Hetal Dholaria, Dorte Schou Nørøxe, Hiroaki Goto, David S. Ziegler, Frank Y. Lin, D. Williams Parsons, Holly Lindsay, Tai‐Tong Wong, Yen‐Lin Liu, Kuo-Sheng Wu, Andrea Franson, Eugene Hwang, Ana Aguilar-Bonilla, Sylvia Cheng, Chantel Cacciotti, Maura Massimino, Elisabetta Schiavello, Paul Wood, Lindsey M. Hoffman, Andréa Maria Cappellano, Álvaro Lassaletta, An Van Damme, Anna Llort, Nicolas U. Gerber, Mariella Spalato Ceruso, Anne Bendel, Maggie Skrypek, Dima Hamideh, Naureen Mushtaq, Andrew W. Walter, Nada Jabado, Aysha Alsahlawi, Jean‐Pierre Farmer, Christina Coleman, Sabine Mueller, Claire Mazewski, Dolly Aguilera, Nathan Robison, Katrina O’Halloran, Samuel Abbou, Pablo Berlanga, Birgit Geoerger, Ingrid Øra, Christopher L. Moertel, Evangelia Razis, Anastasia Vernadou, François Ducray, Charlotte Bronnimann, Romuald Seizeur, Matthew Clarke, Adam Resnick, Mélanie Alves, Chris Jones, François Doz, Theodore W. Laetsch, Sébastien Perreault

    Baskı/Yayın Bilgisi 2024
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: